| 35686924 | The BILAG-2004 index is associated with development of new damage in SLE. | Rheumatology (Oxford) | 2023 |
| 33787088 | Comparison of Responsiveness of British Isles Lupus Assessment Group 2004 Index, Systemic Lupus Erythematosus Disease Activity Index 2000, and British Isles Lupus Assessment Group 2004 Systems Tally. | Arthritis Care Res (Hoboken) | 2022 |
| 33325488 | Flares in patients with systemic lupus erythematosus. | Rheumatology (Oxford) | 2021 |
| 29207002 | Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study. | Rheumatology (Oxford) | 2018 |
| 30071930 | Muscle loss following a single high-dose intramuscular injection of corticosteroids to treat disease flare in patients with rheumatoid arthritis. | Eur J Rheumatol | 2018 |
| 30538814 | Progression of subclinical and clinical cardiovascular disease in a UK SLE cohort: the role of classic and SLE-related factors. | Lupus Sci Med | 2018 |
| 29306872 | Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study. | Ann Rheum Dis | 2018 |
| 28188239 | Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). | Ann Rheum Dis | 2017 |
| 26816223 | Sensitivity to Change and Minimal Important Differences of the LupusQoL in Patients With Systemic Lupus Erythematosus. | Arthritis Care Res (Hoboken) | 2016 |
| 26414681 | Can Creatine Supplementation Improve Body Composition and Objective Physical Function in Rheumatoid Arthritis Patients? A Randomized Controlled Trial. | Arthritis Care Res (Hoboken) | 2016 |
| 27288209 | Tight control of disease activity fails to improve body composition or physical function in rheumatoid arthritis patients. | Rheumatology (Oxford) | 2016 |
| 24284280 | A perspective on proteomics in cell biology. | Trends Cell Biol | 2014 |
| 27201724 | Is the Disease-Specific Lupusqol Sensitive To Changes of Disease Activity In Systemic Lupus Erythematosus Patients After Treatment of A Flare? | Value Health | 2014 |
| 27447310 | Near Real-Time Processing of Proteomics Data Using Hadoop. | Big Data | 2014 |
| 25404746 | Proteomic and 3D structure analyses highlight the C/D box snoRNP assembly mechanism and its control. | J Cell Biol | 2014 |
| 24758887 | Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study. | Rheumatology (Oxford) | 2014 |
| 24596151 | A proteomic chronology of gene expression through the cell cycle in human myeloid leukemia cells. | Elife | 2014 |
| 23242552 | Global subcellular characterization of protein degradation using quantitative proteomics. | Mol Cell Proteomics | 2013 |
| 24454385 | A simple step test to estimate cardio-respiratory fitness levels of rheumatoid arthritis patients in a clinical setting. | Int J Rheumatol | 2013 |
| 24043423 | Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. | Mol Cell Proteomics | 2013 |
| 21937730 | A quantitative spatial proteomics analysis of proteome turnover in human cells. | Mol Cell Proteomics | 2012 |
| 22908329 | The BILAG-2004 systems tally--a novel way of representing the BILAG-2004 index scores longitudinally. | Rheumatology (Oxford) | 2012 |
| 22298908 | Construct and criterion validity of the short form-6D utility measure in patients with systemic lupus erythematosus. | J Rheumatol | 2012 |
| 22002106 | Systematic analysis of protein pools, isoforms, and modifications affecting turnover and subcellular localization. | Mol Cell Proteomics | 2012 |
| 21245073 | The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients. | Rheumatology (Oxford) | 2011 |
| 22870486 | The efficacy and safety of tacrolimus in rheumatoid arthritis. | Ther Adv Musculoskelet Dis | 2011 |
| 21893561 | An analysis of the metabolic syndrome phenotype in systemic lupus erythematosus. | Lupus | 2011 |
| 21365760 | Mass spectrometry-based immuno-precipitation proteomics - the user's guide. | Proteomics | 2011 |
| 21403833 | Benefits of exercise in rheumatoid arthritis. | J Aging Res | 2011 |
| 20023298 | Establishment of a protein frequency library and its application in the reliable identification of specific protein interaction partners. | Mol Cell Proteomics | 2010 |
| 20810500 | The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosus. | J Rheumatol | 2010 |
| 20864038 | HSP90 and its R2TP/Prefoldin-like cochaperone are involved in the cytoplasmic assembly of RNA polymerase II. | Mol Cell | 2010 |
| 20181671 | Numerical scoring for the BILAG-2004 index. | Rheumatology (Oxford) | 2010 |
| 20007814 | Health-related quality of life, smoking and carotid atherosclerosis in white British women with systemic lupus erythematosus. | Lupus | 2010 |
| 18984612 | NOPdb: Nucleolar Proteome Database--2008 update. | Nucleic Acids Res | 2009 |
| 19779027 | Numerical scoring for the Classic BILAG index. | Rheumatology (Oxford) | 2009 |
| 19395542 | The BILAG-2004 index is sensitive to change for assessment of SLE disease activity. | Rheumatology (Oxford) | 2009 |
| 19426539 | Biomarkers of oxidant stress, insulin sensitivity and endothelial activation in rheumatoid arthritis: a cross-sectional study of their association with accelerated atherosclerosis. | BMC Res Notes | 2009 |
| 17384179 | Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype. | Rheumatology (Oxford) | 2007 |
| 17906068 | Meningococcal meningitis in a patient with urticarial vasculitis: is there a link? | J Clin Pathol | 2007 |
| 18050213 | British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus. | Arthritis Rheum | 2007 |
| 17665467 | Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. | Arthritis Rheum | 2007 |
| 16646981 | Activation of transforming growth factor-beta1 and early atherosclerosis in systemic lupus erythematosus. | Arthritis Res Ther | 2006 |
| 16395749 | Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus. | J Rheumatol | 2006 |
| 12867578 | Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management. | Rheumatology (Oxford) | 2004 |
| 15262847 | Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. | Circulation | 2004 |
| 15124239 | Subclinical atherosclerosis in systemic lupus erythematosus. | J Rheumatol | 2004 |
| 11714386 | Genetic epidemiology: systemic lupus erythematosus. | Arthritis Res | 2001 |